[View Larger Version of this Image]
Figure S3.The coated endosome is an intermediate in the targeting of Pmel17 to the stage II premelanosome. Double immunogold labeling with two distinct antibodies directed against Pmel17. PEP13h is directed to the cytoplasmic domain of Pmel17, which becomes inaccessible within the stage II premelanosome. HMB45 is directed to the lumenal domain of Pmel17; recognition by HMB45 requires a conformational change or processing event that occurs in the Golgi apparatus or TGN. (A) Both HMB45 (lum PAG 5) and
PEP13h (Cyt-PAG 10) recognize Pmel17 in the coated endosome (CE). (B) The
PEP13h antibody (cyt -PAG 10) recognizes Pmel17 in the Golgi appara-tus (GA) and small closely apposed vesicles, whereas HMB45 (lum-PAG 5) only reacts poorly with Pmel17 in these compartments. In contrast, stage II melanosomes (II) are highly labeled with HMB45, but no labeling is observed with
PEP13h. Bars, 100 nm.